Hôpital Européen Georges-Pompidou HEGP — Paris

Public research footprint of Hôpital Européen Georges-Pompidou HEGP, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Out-of-hospital Cardiac Arrest (OHCA) · Advanced Renal Cell Carcinoma · Metastatic Colorectal Cancer · HIV Infections

Recently updated registry entries

NCT07483827 — A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in… (Recruiting)
NCT04790370 — Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk… (Active Not Recruiting)
NCT04708288 — To Evaluate the Safety and Clinical Performance of the ARCHIMEDES Biodegradable Biliary… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hôpital Européen Georges-Pompidou HEGP?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.